Sara M. Nolte
Sara Nolte holds a Bachelor of Health Sciences and Masters of Science in Biochemistry & Biomedical Sciences from McMaster University. Her MSc research focused on developing a cancer stem model to study brain metastases from the lung. She then spent a year working on developing cell-based cancer immunotherapies. Throughout a highly productive graduate career, Sara became interested in scientific communication and education, and later pursued a career as a Physician Assistant (PA) in order to build medical expertise. Working as a PA in Emergency Medicine helps her find ways to bridge the gaps between laboratory and clinical science, and to improve scientific and health-related communication with the public. Outside of science, Sara enjoys participating in a variety of sports, and is a competitive Olympic weightlifter hoping to compete at the National level soon!
Posts by: Sara M.
Cell-based therapy approved as alternative to standard UCB transplant for hematological malignancies
In addition to showers, flowers and warmer weather, this spring also brought renewed hope for patients with hematological malignancies undergoing stem cell transplants (SCTs) in the form of the approval of Gamida Cell’s Omisirge® (omidubicel). This cell-based therapy will reduce the risk of life-threatening infections that these patients face during the process of their life-saving […]
Regenerating a degenerative joint: MSCs as treatment for osteoarthritis
While you all know me as a writer for Signals, I actually spend most of time working clinically. When wearing my health-care provider hat as a physician assistant in orthopaedics, I’m often asked about the use of stem cell therapy for the treatment of arthritis. Beyond the fact that stem cell therapy is not currently […]
An immune system and cancer immunotherapy primer
We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more common treatments being used today. What is […]



Comments